Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Go back to Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
(NASDAQ: MCRB) Delayed: 7.74 -0.2 (2.52%)
Previous Close $7.94    52 Week High $44.51 
Open $7.95    52 Week Low $8.05 
Day High $8.06    P/E N/A 
Day Low $7.48    EPS $0.00 
Volume 130,835